Literature DB >> 20585902

Copy-number increase of AURKA in gastric cancers in a Chinese population: a correlation with tumor progression.

Zhengyu Fang1, Yi Xiong, Jiana Li, Li Liu, Manhui Li, Chao Zhang, Wei Zhang, Jun Wan.   

Abstract

The centrosome-associated kinase aurora A (AURKA) has been shown to be involved in genetic instability and to be over-expressed in several human carcinomas including gastric cancers (GCs). The chromosome locus of AURKA, 20q13, is frequently amplified in GCs, and the functional impact of such regions needs to be extensively investigated in large amount of clinical samples. Case-matched tissues of gastric carcinomas and adjacent normal epithelium (n=141) were included in this study. Quantitative PCR was carried out to examine the copy number and mRNA expression of AURKA in GCs. Our results showed copy-number gains of AUKRA were detected in a relative high percentage of GC samples (30.5%, 43 out of 141). There was a positive correlation between copy-number increase of AURKA and tumor progression. And copy-number gains of AURKA also showed a positive correlation with mRNA over-expression in GCs. However, expression level of AURKA mRNA was also enhanced in the group of GC samples with unaltered copy numbers. These findings indicated that sporadic gastric cancers exhibit different mechanisms of AURKA regulation and that this may impact the efficacy of aurora-targeted therapies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20585902     DOI: 10.1007/s12032-010-9602-4

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  42 in total

1.  AURKA amplification, chromosome instability, and centrosome abnormality in human pancreatic carcinoma cells.

Authors:  Jijiang Zhu; James L Abbruzzese; Julie Izzo; Walter N Hittelman; Donghui Li
Journal:  Cancer Genet Cytogenet       Date:  2005-05

Review 2.  Genetic variation in human gene expression.

Authors:  Emmanouil T Dermitzakis; Barbara E Stranger
Journal:  Mamm Genome       Date:  2006-06-12       Impact factor: 2.957

Review 3.  Side effects of genome structural changes.

Authors:  Alexandre Reymond; Charlotte N Henrichsen; Louise Harewood; Giuseppe Merla
Journal:  Curr Opin Genet Dev       Date:  2007-10-24       Impact factor: 5.578

4.  Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus.

Authors:  V Agnese; D Cabibi; D Calcara; M Terrasi; G Pantuso; E Fiorentino; C Intrivici; G Colucci; F Aragona; N Gebbia; V Bazan; A Russo
Journal:  Ann Oncol       Date:  2007-06       Impact factor: 32.976

5.  Segmental copy number variation shapes tissue transcriptomes.

Authors:  Charlotte N Henrichsen; Nicolas Vinckenbosch; Sebastian Zöllner; Evelyne Chaignat; Sylvain Pradervand; Frédéric Schütz; Manuel Ruedi; Henrik Kaessmann; Alexandre Reymond
Journal:  Nat Genet       Date:  2009-03-08       Impact factor: 38.330

6.  Integrated analysis of copy number alterations and gene expression: a bivariate assessment of equally directed abnormalities.

Authors:  Martin Schäfer; Holger Schwender; Sylvia Merk; Claudia Haferlach; Katja Ickstadt; Martin Dugas
Journal:  Bioinformatics       Date:  2009-10-14       Impact factor: 6.937

7.  The clinical significance of Aurora-A/STK15/BTAK expression in human esophageal squamous cell carcinoma.

Authors:  Eiji Tanaka; Yosuke Hashimoto; Tetsuo Ito; Tomoyuki Okumura; Takatsugu Kan; Go Watanabe; Masayuki Imamura; Johji Inazawa; Yutaka Shimada
Journal:  Clin Cancer Res       Date:  2005-03-01       Impact factor: 12.531

8.  The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer.

Authors:  Sangeeta Rojanala; Haiyong Han; Rubén M Muñoz; Walden Browne; Raymond Nagle; Daniel D Von Hoff; David J Bearss
Journal:  Mol Cancer Ther       Date:  2004-04       Impact factor: 6.261

9.  Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity.

Authors:  Alfred King-Yin Lam; Kate Ong; Yik-Hong Ho
Journal:  Hum Pathol       Date:  2008-03-04       Impact factor: 3.466

Review 10.  Copy-number variation: the end of the human genome?

Authors:  Paul H Dear
Journal:  Trends Biotechnol       Date:  2009-07-01       Impact factor: 19.536

View more
  6 in total

1.  Sentinel lymph node and prognostic factors in gastric cancer.

Authors:  E Orsenigo; S Kusamura; C Staudacher
Journal:  Surg Endosc       Date:  2011-11       Impact factor: 4.584

Review 2.  Gastric cancer and gene copy number variation: emerging cancer drivers for targeted therapy.

Authors:  L Liang; J-Y Fang; J Xu
Journal:  Oncogene       Date:  2015-06-15       Impact factor: 9.867

3.  HDM2 regulation by AURKA promotes cell survival in gastric cancer.

Authors:  Vikas Sehdev; Ahmed Katsha; Janet Arras; Dunfa Peng; Mohammed Soutto; Jeffrey Ecsedy; Alexander Zaika; Abbes Belkhiri; Wael El-Rifai
Journal:  Clin Cancer Res       Date:  2013-11-15       Impact factor: 12.531

4.  Cisplatin-resistant cancer cells are sensitive to Aurora kinase A inhibition by alisertib.

Authors:  Lihong Wang; Janet Arras; Ahmed Katsha; Saif Hamdan; Abbes Belkhiri; Jeffrey Ecsedy; Wael El-Rifai
Journal:  Mol Oncol       Date:  2017-05-30       Impact factor: 6.603

5.  Recombinant human bone morphogenetic protein-2 inhibits gastric cancer cell proliferation by inactivating Wnt signaling pathway via c-Myc with aurora kinases.

Authors:  Kwang Bok Lee; Hua Jin; Shuai Ye; Byung Hyun Park; Soo Mi Kim
Journal:  Oncotarget       Date:  2016-11-08

6.  Amplification and up-regulation of MIR30D was associated with disease progression of cervical squamous cell carcinomas.

Authors:  You Zhou; Yinghua Hao; Yuxia Li; Ruizhen Li; Ruifang Wu; Shubin Wang; Zhengyu Fang
Journal:  BMC Cancer       Date:  2017-03-29       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.